These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32429421)

  • 1. Broussoflavonol B from
    Jeong JH; Ryu JH
    Molecules; 2020 May; 25(10):. PubMed ID: 32429421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.
    Wang L; Zhao Y; Wu Q; Guan Y; Wu X
    Mol Med Rep; 2018 Mar; 17(3):4299-4306. PubMed ID: 29363722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Cancer Potential of
    An EJ; Kim Y; Lee SH; Ko HM; Chung WS; Jang HJ
    Molecules; 2020 May; 25(10):. PubMed ID: 32422890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Momordica cochinchinensis Spreng. seed extract suppresses breast cancer growth by inducing cell cycle arrest and apoptosis.
    Zheng L; Zhang Y; Liu Y; Yang XO; Zhan Y
    Mol Med Rep; 2015 Oct; 12(4):6300-10. PubMed ID: 26252798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.
    Liu X; Cai W; Niu M; Chong Y; Liu H; Hu W; Wang D; Gao S; Shi Q; Hu J; Zhou X; Yu R
    J Neurooncol; 2015 Feb; 121(3):469-77. PubMed ID: 25528634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
    Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
    Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
    Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J
    Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-α36 expression and inhibits growth of ER-negative breast cancer MDA-MB-231 cells.
    Guo M; Wang M; Deng H; Zhang X; Wang ZY
    Eur J Pharmacol; 2013 Aug; 714(1-3):56-64. PubMed ID: 23769740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broussoflavonol B restricts growth of ER-negative breast cancer stem-like cells.
    Guo M; Wang M; Zhang X; Deng H; Wang ZY
    Anticancer Res; 2013 May; 33(5):1873-9. PubMed ID: 23645733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnolol induces apoptosis in osteosarcoma cells via G0/G1 phase arrest and p53-mediated mitochondrial pathway.
    Zhou S; Wen H; Li H
    J Cell Biochem; 2019 Oct; 120(10):17067-17079. PubMed ID: 31155771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells.
    Yue M; Li S; Yan G; Li C; Kang Z
    Cell Cycle; 2018; 17(2):240-249. PubMed ID: 29301438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53.
    Molinuevo R; Freije A; de Pedro I; Stoll SW; Elder JT; Gandarillas A
    Oncogene; 2017 Feb; 36(7):956-965. PubMed ID: 27452522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
    Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
    J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1.
    Cınar V; Hamurcu Z; Guler A; Nurdinov N; Ozpolat B
    Breast Cancer; 2022 Nov; 29(6):1106-1120. PubMed ID: 36006564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diarylheptanoids suppress proliferation of pancreatic cancer PANC-1 cells through modulating shh-Gli-FoxM1 pathway.
    Dong GZ; Jeong JH; Lee YI; Lee SY; Zhao HY; Jeon R; Lee HJ; Ryu JH
    Arch Pharm Res; 2017 Apr; 40(4):509-517. PubMed ID: 28258481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
    Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
    PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.